# A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis

> **NCT06767540** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Akeso** · enrollment: 198 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Placebo
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06767540
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-23
- **Primary completion:** 2027-07-10
- **Final completion:** 2027-07-10
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06767540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06767540, "A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06767540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*